The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
High-Sensitivity ST2 for Prediction of Adverse Outcomes in Chronic Heart Failure
Open accessAbstract
Background—: Soluble ST2 reflects activity of an interleukin-33–dependent cardioprotective signaling axis and is a diagnostic and prognostic marker in acute heart failure. The use of ST2 in chronic heart failure has not been well defined. Our objective was to determine whether plasma ST2 levels predict adverse outcomes in chronic heart failure in the context of current approaches. Methods and Results—: We determined the association between ST2 level and risk of death or transplantation in a multicenter, prospective cohort of 1141 chronic heart failure outpatients. Adjusted Cox models, receiver operating characteristic analyses, and risk reclassification metrics were used to assess the value of ST2 in predicting risk beyond currently used factors. After a median of 2.8 years, 267 patients (23%) died or underwent heart transplantation. Patients in the highest ST2 tertile (ST2 >36.3 ng/mL) had a markedly increased risk of adverse outcomes compared with the lowest tertile (ST2 ≤22.3 ng/mL), with an unadjusted hazard ratio of 3.2 (95% confidence interval [CI], 2.2 to 4.7; P <0.0001) that remained significant after multivariable adjustment (adjusted hazard ratio, 1.9; 95% CI, 1.3 to 2.9; P =0.002). In receiver operating characteristic analyses, the area under the curve for ST2 was 0.75 (95% CI, 0.69 to 0.79), which was similar to N-terminal pro-B–type natriuretic peptide (NT-proBNP) (area under the curve, 0.77; 95% CI, 0.72 to 0.81; P =0.24 versus ST2) but lower than the Seattle Heart Failure Model (area under the curve, 0.81 (95% CI, 0.77 to 0.85; P =0.014 versus ST2). Addition of ST2 and NT-proBNP to the Seattle Heart Failure Model reclassified 14.9% of patients into more appropriate risk categories ( P =0.017). Conclusions—: ST2 is a potent marker of risk in chronic heart failure and when used in combination with NT-proBNP offers moderate improvement in assessing prognosis beyond clinical risk scores.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885 · cited 1×
“Systolic blood pressure, mm Hg 114 (20) 116 (19) 116 (21) 111 (19) 0.”
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., Ford, E., Furie, K., Go, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191259 · Cited by 3,908
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., Ford, E., Furie, K., Go, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191261 · Cited by 3,140
Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
Heagerty, P. J., Lumley, T., & Pepe, M. S. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00337.x · Cited by 2,854
The Seattle Heart Failure Model: Prediction of Survival in Heart Failure
Levy, W. C., Mozaffarian, D., Linker, D. T., Sutradhar, S. C., Anker, S. D., Cropp, A. B., Anand, I., Maggioni, A., Burton, P., Sullivan, M. D., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.584102 · Cited by 2,021
Self-citationJessup, M., & Brozena, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021498 · Cited by 1,564
Self-citationGreenland, P. (2008) · Statistics in Medicine · doi:10.1002/sim.2976 · Cited by 1,300
Braunwald, E. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800239 · Cited by 1,257
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system
Sanada, S., Hakuno, D., Higgins, L. J., Schreiter, E. R., McKenzie, A. N. J., & Lee, R. T. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30634 · Cited by 1,044
The IL-33/ST2 pathway: therapeutic target and novel biomarker
Kakkar, R., & Lee, R. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2660 · Cited by 794
Benchmarks for the Assessment of Novel Cardiovascular Biomarkers
Morrow, D. A., & de Lemos, J. A. (2007) · Circulation · doi:10.1161/circulationaha.106.683110 · Cited by 561
Measurement of the Interleukin Family Member ST2 in Patients With Acute Dyspnea
Januzzi, J. L., Peacock, W. F., Maisel, A. S., Chae, C. U., Jesse, R. L., Baggish, A. L., O’Donoghue, M., Sakhuja, R., Chen, A. A., van Kimmenade, R. R. J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.05.014 · Cited by 522
Self-citationIdentification of Serum Soluble ST2 Receptor as a Novel Heart Failure Biomarker
Weinberg, E. O., Shimpo, M., Hurwitz, S., Tominaga, S.-I., Rouleau, J.-L., & Lee, R. T. (2003) · Circulation · doi:10.1161/01.cir.0000047274.66749.fe · Cited by 503
Cook, N. R., & Ridker, P. M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00007 · Cited by 458
Shimpo, M., Morrow, D. A., Weinberg, E. O., Sabatine, M. S., Murphy, S. A., Antman, E. M., & Lee, R. T. (2004) · Circulation · doi:10.1161/01.cir.0000127958.21003.5a · Cited by 411
Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure
Rehman, S. U., Mueller, T., & Januzzi, J. L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.042 · Cited by 386
Sabatine, M. S., Morrow, D. A., Higgins, L. J., MacGillivray, C., Guo, W., Bode, C., Rifai, N., Cannon, C. P., Gerszten, R. E., & Lee, R. T. (2008) · Circulation · doi:10.1161/circulationaha.107.728022 · Cited by 314
Prediction of Mode of Death in Heart Failure: The Seattle Heart Failure Model
Mozaffarian, D., Anker, S. D., Anand, I., Linker, D. T., Sullivan, M. D., Cleland, J. G. F., Carson, P. E., Maggioni, A. P., Mann, D. L., Pitt, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.687103 · Cited by 301
Self-citationMulticenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay
Yeo, K.-T. J., Wu, A. H. B., Apple, F. S., Kroll, M. H., Christenson, R. H., Lewandrowski, K. B., Sedor, F. A., & Butch, A. W. (2003) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.08.016 · Cited by 296
Self-citationWeir, R. A. P., Miller, A. M., Murphy, G. E. J., Clements, S., Steedman, T., Connell, J. M. C., McInnes, I. B., Dargie, H. J., & McMurray, J. J. V. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.08.047 · Cited by 280
Assessment of Claims of Improved Prediction Beyond the Framingham Risk Score
Tzoulaki, I. (2009) · JAMA · doi:10.1001/jama.2009.1757 · Cited by 276
Bartunek, J., Delrue, L., Van Durme, F., Muller, O., Casselman, F., De Wiest, B., Croes, R., Verstreken, S., Goethals, M., de Raedt, H., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.027 · Cited by 244
Dieplinger, B., Januzzi, J. L., Steinmair, M., Gabriel, C., Poelz, W., Haltmayer, M., & Mueller, T. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.08.010 · Cited by 240
Pascual-Figal, D. A., Ordoñez-Llanos, J., Tornel, P. L., Vázquez, R., Puig, T., Valdés, M., Cinca, J., de Luna, A. B., & Bayes-Genis, A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.041 · Cited by 233
Levy, W. C., Lee, K. L., Hellkamp, A. S., Poole, J. E., Mozaffarian, D., Linker, D. T., Maggioni, A. P., Anand, I., Poole-Wilson, P. A., Fishbein, D. P., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.816884 · Cited by 222
Self-citationSerial Sampling of ST2 Predicts 90-Day Mortality Following Destabilized Heart Failure
Boisot, S., Beede, J., Isakson, S., Chiu, A., Clopton, P., Januzzi, J., Maisel, A. S., & Fitzgerald, R. L. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.06.415 · Cited by 207
Mueller, T., Dieplinger, B., Gegenhuber, A., Poelz, W., Pacher, R., & Haltmayer, M. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.096560 · Cited by 173
Assessing New Biomarkers and Predictive Models for Use in Clinical Practice: A Clinician's Guide
McGeechan, K., Macaskill, P., Irwig, L., Liew, G., & Wong, T. Y. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.21.2304 · Cited by 141
Neuregulin-1β is Associated with Disease Severity and Adverse Outcomes in Chronic Heart Failure
Ky, B., Kimmel, S., Safa, R., Putt, M., Sweitzer, N., Fang, J. C., Sawyer, D., & Cappola, T. (2009) · Circulation · doi:10.1161/circulationaha.109.856310 · Cited by 98
Self-citationReclassification Calculations for Persons With Incomplete Follow-up
Steyerberg, E. W., & Pencina, M. J. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-3-201002020-00019 · Cited by 88
Vorovich, E., Chuai, S., Li, M., Averna, J. F., Marwin, V. M., Wolfe, D. J., Reilly, M. P., & Cappola, T. P. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.01.007 · Cited by 27
Self-citation
Cited by
Braunwald, E. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2012.10.002 · Cited by 730
Chow, S. L., Maisel, A. S., Anand, I., Bozkurt, B., de Boer, R. A., Felker, G. M., Fonarow, G. C., Greenberg, B., Januzzi, J. L., Kiernan, M. S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000490 · Cited by 601
Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study
Wang, T. J., Wollert, K. C., Larson, M. G., Coglianese, E., McCabe, E. L., Cheng, S., Ho, J. E., Fradley, M. G., Ghorbani, A., Xanthakis, V., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.129437 · Cited by 482
Role of IL-33 in inflammation and disease
Miller, A. M. (2011) · Journal of Inflammation · doi:10.1186/1476-9255-8-22 · Cited by 481
Biomarkers and diagnostics in heart failure
Gaggin, H. K., & Januzzi, J. L. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.014 · Cited by 423
Metadata
- Authors
- Ky, B., French, B., McCloskey, K., Rame, J. E., McIntosh, E., Shahi, P., Dries, D. L., Tang, W. H. W., Wu, A. H. B., Fang, J. C., Boxer, R., Sweitzer, N. K., Levy, W. C., Goldberg, L. R., Jessup, M., & Cappola, T. P.
- Venue
- Circulation: Heart Failure
- Published
- 2011-03
- Volume
- 4
- Issue
- 2
- Pages
- 180-187
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2099610554
- Cited by
- 376
- References
- 32
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.